Pharmaceutical Giant Plotted to Destroy Cancer Drugs to Drive Prices Up 4,000%

How far is the pharmaceutical industry willing to go to increase its bottom line? The Independent reports that industry giant Aspen Pharmacare purchased five cancer drugs from GlaxoSmithKline (GSK) and used this near-monopoly to hit European buyers with extortionate 40-fold price increases. What makes this gouging possible is a rule that allows drug companies to increase the price of drugs that have been rebranded. Interestingly, GlaxoSmithKline’s relationship with Aspen Pharmacare...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports